| 000 | 01305 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513103851.0 | ||
| 264 | 0 | _c19970314 | |
| 008 | 199703s 0 0 eng d | ||
| 022 | _a0304-3940 | ||
| 024 | 7 |
_a10.1016/0304-3940(96)13065-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKotake, Y | |
| 245 | 0 | 0 |
_aChronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate. _h[electronic resource] |
| 260 |
_bNeuroscience letters _cOct 1996 |
||
| 300 |
_a69-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain Chemistry _xphysiology |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aIsoquinolines _xtoxicity |
| 650 | 0 | 4 | _aMacaca fascicularis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeurotoxins _xtoxicity |
| 650 | 0 | 4 |
_aParkinson Disease, Secondary _xchemically induced |
| 650 | 0 | 4 | _aTetrahydroisoquinolines |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aYoshida, M | |
| 700 | 1 | _aOgawa, M | |
| 700 | 1 | _aTasaki, Y | |
| 700 | 1 | _aHirobe, M | |
| 700 | 1 | _aOhta, S | |
| 773 | 0 |
_tNeuroscience letters _gvol. 217 _gno. 1 _gp. 69-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0304-3940(96)13065-2 _zAvailable from publisher's website |
| 999 |
_c8898292 _d8898292 |
||